Evidence map›Paper›PMID 41523835›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2025

Hematology specialist nurse-led continuity-of-care for high-risk hematopoietic cell transplantation recipients.

Ting Wang, Li Wu, Aiyun Jin, Xiaming Zhu, Wenjun Xie, Yun Fang, Yanyan Chai, Songhua Luan, Xin Du, Michelle Kenyon and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ting WangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing 100044, China.
Li WuDepartment of Aged Care, HammondCare, Level 4, 207B Pacific Highway, St Leonards, New South Wales 2065, Australia.
Aiyun JinDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Xiaming ZhuDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Wenjun XieInstitute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 30000, China.
Yun FangDepartment of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Yanyan ChaiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Songhua LuanDepartment of Hematology, Chinese PLA General Hospital, Beijing 100141, China.
Xin DuDepartment of Hematology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
Michelle KenyonDepartment of Hematology, King's College Hospital NHS Foundation Trust, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom.
Xia YanPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41523835
PMCPMC12780784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.